By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
November 15, 2025 2:07 AM EST
Medical Herald
Search
  • Health Conditions
    Health ConditionsShow More
    Diet Drinks Linked to Increased Liver Disease Risk, Study Finds
    Health Conditions
    Experts Urge Rethink on Prediabetes Diagnosis and Treatment
    Diabetes
    Study Highlights Rising Heart Risks in Pregnant Women
    Pregnancy & Parenting
    ‘New Mom School’ Helps Women Through Postpartum Challenges
    Pregnancy & Parenting
    Beware of Counterfeit Weight Loss Drugs Sold Online
    Weight Management
  • Wellness & Self-Care
    Wellness & Self-CareShow More
    Heart Health: Simple Daily Habits for Everyone
    Heart Health
    Introducing the Hormometer: Track Cortisol at Home
    Wellness & Self-Care
    First Responders Turn to Ketamine for Mental Health Relief
    Mental Health
    Enjoy Healthy Living This Fall with a Delicious Protein Shake
    Healthy Living
    Top 3 Bedtime Yoga Poses for Better Sleep
    Wellness & Self-Care
  • Nutrition & Fitness
    Nutrition & FitnessShow More
    Fibermaxxing: The Rising Trend in Nutritional Focus
    Diet & Nutrition
    Gutzy Organic Launches Healthy Prebiotic Protein Smoothies
    Diet & Nutrition
    Achieve Your Nutrition Goals with Nourish and Insurance
    Nutrition & Fitness
    Delicious Roasted Salmon with Olives from Dan Pelosi
    Healthy Recipes
    Short Exercise Bursts: A New Trend in Fitness?
    Fitness
  • Innovation
    InnovationShow More
    Dr. Hosen Kiat: Advancing the Frontiers of Cardiovascular Science
    Innovation
    FDA Issues Warning for J&J and Legend’s Cancer Treatment Carvykti
    Drugs & Medications
    GLP-1 Medications Transform Health and Household Budgets
    Drugs & Medications
    Drug Tied to Fatal Crashes and Risks of Weight-Loss Pills
    Drugs & Medications
    GLP-1 Medications Like Ozempic May Affect Medical Scan Results
    Drugs & Medications
  • News
    NewsShow More
    Advances in Nigeria’s Real-Time NTD Treatment Reporting System
    News
    WIC Program Secures $300M Amid Government Shutdown Concerns
    News
    Guy Benson Shares Early Cancer Diagnosis and Encourages Skin Checks
    News Skin Care
    Congress Stalemate Threatens Health Insurance for Millions
    News
    Explorer Middle School Unveils New Gymnasium
    News
Font ResizerAa
Medical HeraldMedical Herald
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Search
  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
Follow US
Copyright © 2025, Medical Herald. All Rights Reserved.
Home » Innovation » Steakholder Foods to Raise $1.5 Million Through Warrant Exercise

Steakholder Foods to Raise $1.5 Million Through Warrant Exercise

By Samuel Lee
Published: October 3, 2025
Share

Steakholder Foods Ltd., an innovator in alternative proteins based in Rehovot, Israel, has announced a significant financial move as it exercises outstanding warrants for the purchase of its American Depository Shares (ADSs). This development, disclosed on September 30, 2025, marks an important step in the company’s ongoing pursuit of growth and innovation in the food technology sector.

The company will exercise a total of 297,618 warrants originally issued on July 17, 2025. Each warrant allows the purchase of one ADS, with one ADS representing 4,000 ordinary shares. Initially priced at $8.40 per ADS, the exercise price has been reduced to $5.00. According to Steakholder Foods, the transaction is set to close around October 1, 2025, subject to customary conditions.

H.C. Wainwright & Co. is serving as the exclusive placement agent for this transaction, which is anticipated to generate approximately $1.5 million in gross proceeds before accounting for the placement agent’s fees and other related expenses. The company indicated that the new warrants could potentially yield an additional $4.5 million if fully exercised. However, there is no certainty that these new warrants will be exercised.

The anticipated proceeds will support various initiatives, including:
– Additional working capital
– Expansion of its business ventures
– Re-purchasing its own securities
– General corporate purposes

The ADSs associated with the existing warrants have been registered under an effective registration statement, providing a clear framework for stakeholders going forward.

In exchange for cash exercise of the existing warrants, Steakholder Foods will issue new unregistered Series A and Series B warrants.
– The Series A warrants will allow for the purchase of up to 297,618 ADSs, while the Series B warrants cover 595,236 ADSs.
– Both series will have an exercise price set at $5.00 per share.
– The Series A warrants can be exercised starting from the effective date of shareholder approval concerning an increase in authorized shares and will expire five years after this date. Meanwhile, the Series B warrants will become exercisable on the same shareholder approval date and will remain valid for eighteen months thereafter.

It’s important to note the new warrants are unregistered under the Securities Act of 1933 and may not be sold in the United States unless under a registered agreement or a qualifying exemption.

In its statement, Steakholder Foods clarified that this press release should not be interpreted as an offer to sell or solicit an offer to purchase any of its securities, which cannot be transacted in jurisdictions where such offers would be illegal prior to proper registration or qualification.

Founded in 2019, Steakholder Foods is pushing the boundaries of food technology, particularly in the alternative protein market. The company focuses on creating advanced 3D printing machinery that utilizes proprietary blends made from high-quality raw materials. These innovations aim to help manufacturers produce food products that meet growing consumer expectations for taste, texture, and appearance, while simultaneously providing sustainable alternatives to traditional meat and seafood production.

Steakholder Foods specializes in replicating the complex textures of various meats, including beef steaks, white fish, shrimp, and eel. The company is also exploring ways to integrate cultivated cells, signaling exciting possibilities for the future of food technology.

In connection with this announcement, Steakholder Foods included forward-looking statements regarding the potential outcomes of this warrant exercise and other future endeavors. These statements, while based on the company’s current expectations, carry inherent risks and uncertainties that could lead to divergence from projected outcomes. Specifically, factors such as market conditions, the success of technology developments, and regulatory approvals could significantly influence the actual results.

Steakholder Foods prompts investors to exercise caution when relying on forward-looking statements, as they may change with evolving market dynamics and the emergence of new risks. The company emphasizes its commitment to transparency and upholding legal standards in its communications.

For further inquiries, investors can reach out to Steakholder Foods via the provided contacts:
– Press Contact: Info@steakholderfoods.com
– Investor Contact: Investors@steakholderfoods.comNutrition & Diet

TAGGED:Steakholder Foods
Share This Article
Facebook LinkedIn Email Copy Link
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

HOT NEWS

Dr. Hosen Kiat: Advancing the Frontiers of Cardiovascular Science

November 11, 2025

Diet Drinks Linked to Increased Liver Disease Risk, Study Finds

New research suggests both sugary and diet sodas may increase liver disease risk, urging experts…

November 11, 2025

FDA Issues Warning for J&J and Legend’s Cancer Treatment Carvykti

FDA warns of severe gut inflammation linked to Carvykti, a cancer therapy for multiple myeloma,…

November 11, 2025

GLP-1 Medications Transform Health and Household Budgets

GLP-1 drugs are revolutionizing weight loss—and personal finance. As health improves, Americans are rethinking budgets,…

November 11, 2025

YOU MAY ALSO LIKE

GLP-1 Medications Like Ozempic May Affect Medical Scan Results

GLP-1 drugs like Ozempic may alter PET and CT scan readings, leading to potential misinterpretations and unnecessary procedures, researchers warn.

November 4, 2025

Sam’s Club Offers Affordable Ozempic, Wegovy for Weight Loss

Sam’s Club launches $499 pricing for Ozempic and Wegovy, expanding access to weight-loss meds and same-day delivery for refrigerated prescriptions.

October 21, 2025

FDA to Decide on Biohaven’s Ataxia Treatment in November

As the FDA weighs Biohaven’s SCA drug approval, patients and investors await a pivotal decision that could reshape rare disease…

October 27, 2025

Discovering My Sleep Patterns with SleepSpace App Insights

SleepSpace helped me uncover hidden sleep issues using just my phone and AI support—no wearables, just insights from Dr. Snooze…

October 3, 2025

Medical Herald is your trusted source for medical news, scientific research, health policy updates, and expert insights from around the world. 

Category

  • Health Conditions
  • Wellness & Self-Care
  • Nutrition & Fitness
  • Innovation
  • News
  • Privacy Policy
  • About Us
  • Contact

Follow US: 

  • Grow Big Agency Sites:
  • London Business Journal
Copyright © 2025, Medical Herald. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?